Vicarious Surgical Inc. (NYSE:RBOT) Sees Significant Increase in Short Interest

Vicarious Surgical Inc. (NYSE:RBOT) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 207,502 shares, a growth of 37.4% from the November 30th total of 151,012 shares. Based on an average trading volume of 219,487 shares, the days-to-cover ratio is currently 0.9 days. Approximately 3.5% of the shares of the stock are short sold. Approximately 3.5% of the shares of the stock are short sold. Based on an average trading volume of 219,487 shares, the days-to-cover ratio is currently 0.9 days.

Vicarious Surgical Stock Performance

RBOT traded up $0.30 during trading on Thursday, reaching $2.16. 238,241 shares of the company’s stock were exchanged, compared to its average volume of 162,525. The company’s fifty day moving average price is $3.32 and its 200-day moving average price is $5.98. The firm has a market capitalization of $14.15 million, a PE ratio of -0.24 and a beta of 1.51. Vicarious Surgical has a fifty-two week low of $1.81 and a fifty-two week high of $18.97.

Vicarious Surgical (NYSE:RBOT) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($1.91) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.37) by $0.46. Research analysts forecast that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

RBOT has been the subject of a number of research analyst reports. BTIG Research reiterated a “neutral” rating on shares of Vicarious Surgical in a report on Friday, December 12th. Wall Street Zen raised shares of Vicarious Surgical to a “sell” rating in a report on Saturday, September 13th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Vicarious Surgical in a research note on Wednesday, October 8th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Reduce” and an average target price of $7.00.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Connective Capital Management LLC acquired a new position in Vicarious Surgical during the 3rd quarter worth approximately $169,000. DNB Asset Management AS grew its position in Vicarious Surgical by 12.1% in the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after purchasing an additional 3,154 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Vicarious Surgical by 22.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after buying an additional 3,615 shares during the last quarter. Institutional investors and hedge funds own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.